A randomized study comparing docetaxel/cyclophosphamide (TC), 5-fluorouracil/epirubicin/cyclophosphamide (FEC) followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer
| Image |  |
|---|---|
| Description | scientific article published on 13 March 2020 |
| Author/s |
author: Hiroshi Ishiguro Norikazu Masuda Masakazu Toi Shinji Ohno |
| Publication date | March 13, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |